From: Pneumonia scoring systems for severe COVID-19: which one is better
 | Patients |
---|---|
Age | 61 (20–96) |
Gender | Â |
 Male | 36 (67.9%) |
 Female | 17 (33.1%) |
 BMI | 25.8 (19.6–30.5) |
Chronic diseases | 23 (43.4%) |
 Hypertension | 20 (37.7) |
 Diabetes | 9 (17) |
 Heart disease | 11 (20.8) |
 Cerebrovascular disease | 3 (5.7) |
Treatment and outcome | Â |
 Noninvasive ventilator support | 26 (49.1%) |
 Invasive ventilator support | 20 (37.7%) |
 Cured | 37 (69.8%) |
 Death | 16 (30.2%) |
Course of disease | Â |
 Onset to admission | 7 (1–31) |
 Onset to noninvasive ventilator support | 12 (6–32) |
 Onset to invasive ventilator support | 20 (9–38) |
 Onset to death | 25 (10–44) |
 Onset to discharge | 35 (7–53) |